{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:29:59Z","timestamp":1787772599192,"version":"build-2784847793"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The near total absence of routine Hepatitis Delta Virus (HDV) screening in many countries in sub-Saharan Africa is a major challenge to understanding the burden of HDV in the region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To evaluate Hepatitis Delta Virus screening practices and associated factors among clinicians in Nigeria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted in June\u2013July 2022, in which a self-administered questionnaire that inquired about HDV awareness, screening practices, and treatment options was shared electronically with consenting clinicians practicing in Nigeria. At the end of the survey, data was analyzed using descriptive and inferential statistics. The level of significance was set at 0.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      At the end of the survey, 210 of the 213 responses retrieved from respondents were analyzed. The respondent\u2019s mean age was 38.60 \u00b1 7.27 years with a male-to-female ratio of 1:2.5. They comprised 13.8% gastroenterologists and 86.2% respondents in other areas of clinical medicine. The study showed that 89.5% of the respondents knew that HDV infection occurs only in hepatitis B virus (HBV)-infected individuals. Most (91.4%) respondents do not screen for HDV in chronic HBV patients, mainly due to the non-availability of screening tools and lack of awareness of any screening test for HDV. Research interest was reported as the reason for screening among clinicians who had ever screened for HDV. Pegylated interferon was the main regimen used for treatment by 87.5% of respondents. About 2% did not know treatment options for HDV. A significant association between knowledge of HDV infection and area of specialty, as well as the nature of medical practice was noted (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008 and 0.013, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study showed a high level of awareness of HDV dependency on HBV, for natural infection to occur. However, it documented very minimal HDV screening in clinical settings and factors affecting screening among clinicians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_27_24","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T05:00:23Z","timestamp":1724648423000},"page":"1004-1011","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Hepatitis Delta Virus Surveillance Practice among Clinicians in Nigeria: A Cross-Sectional Survey"],"prefix":"10.4103","volume":"27","author":[{"given":"IM","family":"Ifeorah","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Science, Faculty of Health Science and Technology, College of Medicine, University of Nigeria Enugu Campus, Enugu State, Nigeria"},{"name":"Center for Translation and Implementation Research, College of Medicine, University of Nigeria Ituku-Ozalla Campus, Enugu State, Nigeria"},{"name":"Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Musa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Federal Teaching Hospital Katsina, Katsina State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LO","family":"Abdulkareem","sequence":"additional","affiliation":[{"name":"Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria"},{"name":"Department of Internal Medicine, University of Abuja Teaching Hospital, Gwagwalada, Federal Capital Territory, Abuja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OO","family":"Oguntoye","sequence":"additional","affiliation":[{"name":"Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria"},{"name":"Department of Medicine, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OD","family":"Gideon","sequence":"additional","affiliation":[{"name":"Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria"},{"name":"Department of Medical Laboratory Sciences, Redeemer's University, Ede, Osun State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AO","family":"Ogunwale","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Health Sciences, Bowen University Iwo, Osun State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CO","family":"Ogu","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, Faculty of Health Science and Technology, College of Medicine, University of Nigeria Enugu Campus, Enugu State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OE","family":"Ariyo","sequence":"additional","affiliation":[{"name":"Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria"},{"name":"Department of Medicine, Division of Infectious Disease and Tropical Medicine, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/v13101912","article-title":"Hepatitis D review: Challenges for the resource-poor setting","volume":"13","author":"Lee","year":"2021","journal-title":"Viruses"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J Hepatol"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gutjnl-2018-317403","article-title":"Devil hepatitis D: An orphan disease or largely underdiagnosed?","volume":"68","author":"Wedemeyer","year":"2019","journal-title":"Gut"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"e0257621","DOI":"10.1371\/journal.pone.0257621","article-title":"Hepatitis B vaccination status and associated factors among students of medicine and health sciences in Wolkite University, Southwest Ethiopia: A cross-sectional study","volume":"16","author":"Haile","year":"2021","journal-title":"PLoS One"},{"key":"R5-20260427","doi-asserted-by":"crossref","first-page":"e2100277","DOI":"10.9745\/GHSP-D-21-00277","article-title":"Implementation approaches for introducing and overcoming barriers to hepatitis B birth-dose vaccine in sub-Saharan Africa","volume":"10","author":"Boisson","year":"2022","journal-title":"Glob Health Sci Pract"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s43162-022-00167-z","article-title":"Assessing the level of knowledge, uptake of hepatitis B virus vaccine, and its determinants among health workers across various levels of health facilities in Ondo, SouthWest, Nigeria","volume":"34","author":"Oni","year":"2022","journal-title":"Egypt J Intern Med"},{"key":"R7-20260427","first-page":"7","article-title":"Epidemiological update: Increasing mortality calls for action 03","year":"2017","journal-title":"Global Hepatitis Report, 2017"},{"key":"R8-20260427","first-page":"1","article-title":"Global hepatitis report 2024: Action for access in low- and middle-income countries"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: A systematic review and meta-analysis","volume":"68","author":"Chen","year":"2018","journal-title":"Gut"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao","year":"2019","journal-title":"J Infect Dis"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06800-6","article-title":"Hepatitis B virus infection in Nigeria: A systematic review and meta-analysis of data published between 2010 and 2019","volume":"21","author":"Ajuwon","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"S1","key":"R12-20260427","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jvh.13797","article-title":"Delta hepatitis epidemiology and the global burden of disease","volume":"30","author":"Kushner","year":"2023","journal-title":"J Viral Hepatitis"},{"key":"R13-20260427","article-title":"Guidelines"},{"key":"R14-20260427","article-title":"SOGHIN-Viral-Hepatitis-Management-Guidelines-2021"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s10620-023-07960-y","article-title":"Diagnosis and management of hepatitis delta virus infection","volume":"68","author":"Pan","year":"2023","journal-title":"Dig Dis Sci"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL clinical practice guidelines on hepatitis delta virus","volume":"79","author":"Brunetto","year":"2023","journal-title":"J Hepatol"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-021-01493-4","article-title":"Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria","volume":"18","author":"Opaleye","year":"2021","journal-title":"Virol J"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-016-0514-6","article-title":"Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria","volume":"13","author":"Opaleye","year":"2016","journal-title":"Virol J"},{"key":"R19-20260427","first-page":"439","article-title":"Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases","volume":"12","author":"Nwokediuko","year":"2009","journal-title":"Niger J Clin Pract"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15321819.2017.1372474","article-title":"Seroprevalence of hepatitis B and delta viruses among HIV-infected population attending anti-retroviral clinic in selected health facilities in Abuja, Nigeria","volume":"38","author":"Ifeorah","year":"2017","journal-title":"J Immunoassay Immunochem"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/jmv.25503","article-title":"Characterization of hepatitis delta virus strains spreading in Abuja, Nigeria","volume":"91","author":"Ifeorah","year":"2019","journal-title":"J Med Virol"},{"key":"R22-20260427","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/15321819.2022.2141578","article-title":"Seroprevalence, co-infection and risk of transmission of Hepatitis B and D virus among hospital attendees in two South-western states in Nigeria","volume":"44","author":"Sobajo","year":"2023","journal-title":"J Immunoassay Immunochem"},{"key":"R23-20260427","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3855\/jidc.13127","article-title":"Hepatitis D virus antibodies and liver function profile among patients with chronic hepatitis B infection in Abuja, Nigeria","volume":"15","author":"Abdulkareem","year":"2021","journal-title":"J Infect Dev Ctries"},{"key":"R24-20260427","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/JCM.02297-13","article-title":"Characterization of hepatitis delta virus in Sub-Saharan Africa","volume":"52","author":"Andernach","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R25-20260427","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12072-015-9684-3","article-title":"Hepatitis C virus as a systemic disease: Reaching beyond the liver","volume":"10","author":"Gill","year":"2015","journal-title":"Hepatol Int"},{"key":"R26-20260427","article-title":"Hepcludex"},{"key":"R27-20260427","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jiz634","article-title":"Hepatitis delta virus infection: A large burden after all?","volume":"221","author":"Yurdaydin","year":"2019","journal-title":"J Infect Dis"},{"key":"R28-20260427","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jvh.13779","article-title":"The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection","volume":"30","author":"Nathani","year":"2023","journal-title":"J Viral Hepat"},{"key":"R29-20260427","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.14309\/ajg.0000000000001947","article-title":"Low performance of hepatitis delta virus testing among 2 National cohorts of chronic hepatitis B patients in the United States","volume":"117","author":"Wong","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R30-20260427","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1007\/s10620-023-07961-x","article-title":"Hepatitis delta virus infection in the United States: If you seek, you may find","volume":"68","author":"Karimi-Sari","year":"2023","journal-title":"Dig Dis Sci"},{"key":"R31-20260427","first-page":"1","article-title":"HBV\/HDV Co-infection: Epidemiological and clinical changes, recent knowledge and future challenges","volume":"11","author":"Sagnelli","year":"2021","journal-title":"Life (Basel)"},{"key":"R32-20260427","doi-asserted-by":"crossref","first-page":"114873","DOI":"10.1016\/j.diagmicrobio.2019.114873","article-title":"Comparison of anti\u2013hepatitis D virus (HDV) ETI-AB-DELTAK-2 assay and the novel LIAISON\u00ae XL MUREX anti-HDV assay in the diagnosis of HDV infection","volume":"95","author":"Rocco","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R33-20260427","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3390\/v13122371","article-title":"A rapid point-of-care test for the serodiagnosis of hepatitis delta virus infection","volume":"13","author":"Lempp","year":"2021","journal-title":"Viruses"},{"key":"R34-20260427","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/hep.28957","article-title":"A novel quantitative microarray antibody capture (Q-MAC) assay identifies an extremely high HDV prevalence amongst HBV infected Mongolians","volume":"66","author":"Chen","year":"2017","journal-title":"Hepatology"},{"key":"R35-20260427","doi-asserted-by":"crossref","article-title":"Dual Practice of Medical Professionals in Public Hospitals in South-Eastern Nigeria: An economic and policy analysis","author":"Eze","DOI":"10.23889\/Suthesis.51641"},{"key":"R36-20260427","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/s12913-017-2701-6","article-title":"Public-on-private dual practice among physicians in public hospitals of Tigray National Regional State, North Ethiopia: Perspectives of physicians, patients and managers","volume":"17","author":"Abera","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"R37-20260427","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.healthpol.2007.03.006","article-title":"Policy and regulatory responses to dual practice in the health sector","volume":"84","author":"Garc\u00eda-Prado","year":"2007","journal-title":"Health Policy"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_27_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:05:23Z","timestamp":1787771123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_27_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_27_24","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"2024-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}